thenoyltrifluoroacetone has been researched along with Kahler Disease in 1 studies
Thenoyltrifluoroacetone: Chelating agent and inhibitor of cellular respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Inhibition of Complex I, using IACS-010759, an orally bioavailable Complex I inhibitor in clinical trials, as well as succinate ubiquinone reductase (SQR) activity of Complex II, using thenoyltrifluoroacetone (TTFA) or introduction of SDHC R72C mutant, independently sensitize resistant MM to venetoclax." | 1.56 | Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. ( Achreja, A; Bajpai, R; Barwick, BG; Boise, LH; Edgar, CL; Gupta, VA; Lonial, S; Matulis, SM; McBrayer, SK; Mittal, A; Nagrath, D; Nooka, AK; Rupji, M; Shanmugam, M; Sharma, A; Siddiqa, AA; Wei, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajpai, R | 1 |
| Sharma, A | 1 |
| Achreja, A | 1 |
| Edgar, CL | 1 |
| Wei, C | 1 |
| Siddiqa, AA | 1 |
| Gupta, VA | 1 |
| Matulis, SM | 1 |
| McBrayer, SK | 1 |
| Mittal, A | 1 |
| Rupji, M | 1 |
| Barwick, BG | 1 |
| Lonial, S | 1 |
| Nooka, AK | 1 |
| Boise, LH | 1 |
| Nagrath, D | 1 |
| Shanmugam, M | 1 |
1 other study available for thenoyltrifluoroacetone and Kahler Disease
| Article | Year |
|---|---|
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Chromosomes, Human, Pair 11; Chromosomes, | 2020 |